Low-dose Interleukin-2
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Low-dose Interleukin-2, covering 2015-10-06 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Low Dose IL-2 for the Treatment of Crohn's Disease [Phase 1, Phase 2]